Ladetto, M., Gutmair, K., Tavarozzi, R., Pawlikowski, A., Schomaker, M., Doorduijn, J., Giné, E., Jerkeman, M., Walewski, J., Hutchings, M., Mey, U., Riise, J., Trneny, M., Vergote, V. K., Horowitz, N. A., Silva, M. G. D., Leppä, S., Jiang, L., Stilgenbauer, S., Kerkhoff, A., Jachimowicz, R. D., Hess, G., Meerten, T. V., Wirths, S., Herhaus, P., Novak, U., Dierlamm, J., Hänel, M., Hanoun, C., Sonnevi, K., Visco, C., Castellino, C., Lemoli, R. M., Zilioli, V. R., Boccomini, C., Pott, C., Klapper, W., Schmidt, C., Dreyling, M., Hoster, E. (2026). Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00705